- Home
- RVMD vs BCH Comparison
RVMD vs BCH Comparison
Compare RVMD & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- BCH
- Stock Information
- Founded
- RVMD 2014
- BCH 1893
- Country
- RVMD United States
- BCH Chile
- Employees
- RVMD N/A
- BCH N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- BCH Commercial Banks
- Sector
- RVMD Health Care
- BCH Finance
- Exchange
- RVMD Nasdaq
- BCH Nasdaq
- Market Cap
- RVMD 10.2B
- BCH 11.6B
- IPO Year
- RVMD 2020
- BCH 2002
- Fundamental
- Price
- RVMD $56.75
- BCH $22.56
- Analyst Decision
- RVMD Strong Buy
- BCH Hold
- Analyst Count
- RVMD 12
- BCH 1
- Target Price
- RVMD $59.25
- BCH $21.00
- AVG Volume (30 Days)
- RVMD 1.5M
- BCH 234.9K
- Earning Date
- RVMD 11-06-2024
- BCH 10-29-2024
- Dividend Yield
- RVMD N/A
- BCH 7.50%
- EPS Growth
- RVMD N/A
- BCH 14.90
- EPS
- RVMD N/A
- BCH 0.02
- Revenue
- RVMD $742,000.00
- BCH $3,231,399,879.00
- Revenue This Year
- RVMD N/A
- BCH N/A
- Revenue Next Year
- RVMD $300.00
- BCH $1.83
- P/E Ratio
- RVMD N/A
- BCH $7.23
- Revenue Growth
- RVMD N/A
- BCH 10.24
- 52 Week Low
- RVMD $20.98
- BCH $20.93
- 52 Week High
- RVMD $62.40
- BCH $25.97
- Technical
- Relative Strength Index (RSI)
- RVMD 58.35
- BCH 34.27
- Support Level
- RVMD $53.69
- BCH $22.87
- Resistance Level
- RVMD $58.83
- BCH $23.49
- Average True Range (ATR)
- RVMD 2.11
- BCH 0.35
- MACD
- RVMD -0.44
- BCH 0.01
- Stochastic Oscillator
- RVMD 35.13
- BCH 0.75
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile) Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.